{"log_id": 6103037992155934824, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 0, "average": 0.9991, "min": 0.998299}, "location": {"width": 155, "top": 194, "height": 34, "left": 274}, "words": "【不良反应】"}, {"probability": {"variance": 0.010294, "average": 0.964175, "min": 0.415654}, "location": {"width": 1107, "top": 253, "height": 41, "left": 294}, "words": "见不良反应是注射部位局部反应,包括轻至中度红斑、搔痒、疼痛和胀等,注射部"}, {"probability": {"variance": 0, "average": 0.994811, "min": 0.994811}, "location": {"width": 34, "top": 248, "height": 34, "left": 1576}, "words": "管"}, {"probability": {"variance": 0.012124, "average": 0.969146, "min": 0.367168}, "location": {"width": 1144, "top": 317, "height": 50, "left": 262}, "words": "位反应通常发生在开始治疗的第一个月内,在随后的治疗中发生频率低注射都位反应平"}, {"probability": {"variance": 0.039314, "average": 0.874604, "min": 0.356861}, "location": {"width": 1114, "top": 383, "height": 50, "left": 274}, "words": "匀行续3一5天。其它不良反应包括头痛、眩晕、皮疹,失眠咳嗽、腹痛、上呼吸道感染"}, {"probability": {"variance": 0, "average": 0.259152, "min": 0.259152}, "location": {"width": 34, "top": 427, "height": 31, "left": 1041}, "words": " 46"}, {"probability": {"variance": 0.031704, "average": 0.883268, "min": 0.438059}, "location": {"width": 1126, "top": 445, "height": 50, "left": 264}, "words": "血压升高、周血淋巴细胞比例增名、鼻炎,发热、关节酸痛、酸痛、困倦,面部肿胀"}, {"probability": {"variance": 0.001097, "average": 0.980611, "min": 0.890391}, "location": {"width": 406, "top": 523, "height": 38, "left": 264}, "words": "转氨酶升高等。部分无需处理"}, {"probability": {"variance": 0.014052, "average": 0.943767, "min": 0.548746}, "location": {"width": 708, "top": 582, "height": 50, "left": 264}, "words": "据国外文献三道同类可类产品的不良反应还有报道"}, {"probability": {"variance": 0.016173, "average": 0.87257, "min": 0.745399}, "location": {"width": 57, "top": 660, "height": 31, "left": 267}, "words": "感染"}, {"probability": {"variance": 0.020982, "average": 0.940428, "min": 0.421838}, "location": {"width": 712, "top": 717, "height": 43, "left": 264}, "words": "最常儿的感染是上呼吸道感染。在国一项安慰剂对照试"}, {"probability": {"variance": 0.000275, "average": 0.9917, "min": 0.938087}, "location": {"width": 354, "top": 714, "height": 36, "left": 1052}, "words": "严重感染的发生率没有明显"}, {"probability": {"variance": 0.018848, "average": 0.947617, "min": 0.362107}, "location": {"width": 1144, "top": 778, "height": 47, "left": 262}, "words": "高。开欧性试验中严重感染的发率和对照试验中的发生率比较也基本相似。发生严重感"}, {"probability": {"variance": 0.013679, "average": 0.948814, "min": 0.387473}, "location": {"width": 1121, "top": 849, "height": 38, "left": 267}, "words": "染的患者除了患有外,还合并有其它可题(如糖尿病、充血性心衰、活动性或慢感染"}, {"probability": {"variance": 1.4e-05, "average": 0.997231, "min": 0.988209}, "location": {"width": 516, "top": 915, "height": 38, "left": 267}, "words": "国内临床试验中没有发生严重感染的报道"}, {"probability": {"variance": 0.000963, "average": 0.959935, "min": 0.915532}, "location": {"width": 111, "top": 986, "height": 34, "left": 269}, "words": "自身抗体"}, {"probability": {"variance": 0.017044, "average": 0.940108, "min": 0.495207}, "location": {"width": 1128, "top": 1043, "height": 43, "left": 264}, "words": "在国外的临床试验中,接受重人Ⅱ型肿瘤坏死因子受体一抗体融合蛋白治行的患者中有"}, {"probability": {"variance": 0.046243, "average": 0.793162, "min": 0.376653}, "location": {"width": 1135, "top": 1114, "height": 38, "left": 269}, "words": "A、抗双链INM抗体新发性的报道和甲氨蝶呤()组比较一自体元明显差"}, {"probability": {"variance": 0.022849, "average": 0.922034, "min": 0.42611}, "location": {"width": 1142, "top": 1174, "height": 50, "left": 262}, "words": "别,但长期应用重组人Ⅱ型肿瘤坏死因子受体一抗体融台蛋白对自身免疫性疾病的影响让"}, {"probability": {"variance": 0, "average": 0.939732, "min": 0.939732}, "location": {"width": 57, "top": 1251, "height": 31, "left": 267}, "words": "楚"}, {"probability": {"variance": 0.011786, "average": 0.855648, "min": 0.735053}, "location": {"width": 118, "top": 1317, "height": 31, "left": 264}, "words": "恶生瘤"}, {"probability": {"variance": 0.010207, "average": 0.951, "min": 0.592355}, "location": {"width": 1135, "top": 1375, "height": 41, "left": 267}, "words": "田外在接受重组人Ⅱ型肿瘤坏死因子受体一抗体融合蛋白汽疗的患者口,观察到有极个别淋"}, {"probability": {"variance": 0.019221, "average": 0.953019, "min": 0.364751}, "location": {"width": 1137, "top": 1441, "height": 38, "left": 267}, "words": "发生,发生率的高低和类风湿关节炎病情严重程度有关。另外还有少量其它类型肿瘦发"}, {"probability": {"variance": 0.007616, "average": 0.953241, "min": 0.716453}, "location": {"width": 982, "top": 1505, "height": 45, "left": 264}, "words": "生:最常见的是结肠,乳腺、肺和1前列腺肿瘤,发生率和类型同正常人群类似"}, {"probability": {"variance": 0.023879, "average": 0.906965, "min": 0.639382}, "location": {"width": 100, "top": 1617, "height": 36, "left": 274}, "words": "【禁忌】"}, {"probability": {"variance": 0.014094, "average": 0.942647, "min": 0.499117}, "location": {"width": 838, "top": 1678, "height": 41, "left": 296}, "words": "败丘症、活动性结核病患者、对本品或制剂中其他成分过敏石禁用"}, {"probability": {"variance": 0.00031, "average": 0.989636, "min": 0.95097}, "location": {"width": 159, "top": 1786, "height": 36, "left": 276}, "words": "【注意事项】"}, {"probability": {"variance": 0.005407, "average": 0.976746, "min": 0.5556}, "location": {"width": 1055, "top": 1847, "height": 43, "left": 299}, "words": "1国外上市同类品种的使用中发生过严重的感染(败血症、致死和危及生命的感染〕"}, {"probability": {"variance": 0.017495, "average": 0.943981, "min": 0.454495}, "location": {"width": 1135, "top": 1911, "height": 45, "left": 267}, "words": "因比,如果患者有反复发作的感染病史或者有易导致感染的潜伏疾病时,在使用不品时应极"}, {"probability": {"variance": 0.004221, "average": 0.952825, "min": 0.860944}, "location": {"width": 84, "top": 1987, "height": 34, "left": 269}, "words": "为慎重"}, {"probability": {"variance": 0.009758, "average": 0.968207, "min": 0.525152}, "location": {"width": 1137, "top": 2044, "height": 45, "left": 264}, "words": "2.在使用本品过程中患者出现上呼吸道反复感染或有其他明显感染倾向时:应及时到医院"}], "language": 3}